Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
1.
Braz. j. med. biol. res ; 52(10): e8926, 2019. graf
Article in English | LILACS | ID: biblio-1039253

ABSTRACT

Humoral immunological defects are frequent and important causes of hypogammaglobulinemia, leading to recurrent infections, autoimmunity, allergies, and neoplasias. Usually, its onset occurs in childhood or during the second and third decades of life; however, the diagnosis is made, on average, 6 to 7 years afterwards. As a consequence, antibody defects can lead to sequelae. Here we describe the clinical-laboratory characteristics, treatment, and prognoses of patients with hypogammaglobulinemia. An observational, cross-sectional, and retrospective study of patients attending the recently established outpatient group of Clinical Immunology between 2013 and 2018 was carried out. Patients with IgG levels below 2 standard deviations from the mean values for the age and/or impaired antibody response were included. Eight patients (3 F and 5 M; median age=41 years (16-65), average symptom onset at 25 years (1-59), and time to diagnosis of 10 years were included. The main infections were: sinusitis in 7/8, pneumonia in 6/8, otitis in 2/8, tonsillitis and diarrhea in 2/8, and diarrhea in 2/8 patients. Hypothyroidism was identified in 4/8 (50%) patients. Rhinitis was found in 7/8 (87.5%) and asthma in 3/8 (37.5%) patients. The tomographic findings were consolidations, atelectasis, emphysema, ground glass opacity, budding tree, bronchial thickening, and bronchiectasis. Immunoglobulin reposition was used between 466 and 600 mg/kg monthly (514.3 mg·kg-1·dose-1). Prophylactic antibiotic therapy was included in 7/8 (87.5%) patients. Airway manifestations prevailed in patients with hypogammaglobulinemia. There is a need for educational work to reduce the time of diagnosis and initiation of treatment, avoiding sequelae.


Subject(s)
Humans , Male , Female , Adolescent , Adult , Middle Aged , Aged , Young Adult , Immunoglobulins, Intravenous/administration & dosage , Agammaglobulinemia/diagnosis , Time Factors , Cross-Sectional Studies , Retrospective Studies , Agammaglobulinemia/drug therapy
2.
Braz. j. med. biol. res ; 51(12): e7813, 2018. tab, graf
Article in English | LILACS | ID: biblio-974251

ABSTRACT

Hereditary angioedema (HAE) is a rare autosomal dominant disease due to C1 esterase inhibitor deficiency (C1-INH). The disease is characterized by subcutaneous and submucosal edema in the absence of urticaria due to the accumulation of bradykinin. This descriptive study aimed to evaluate the clinical characteristics of patients with a confirmed diagnosis of HAE referred to our Outpatient Clinic between December 2009 and November 2017. Fifty-one patients (38 F, 13 M) with a mean age of 32 years (range: 7-70 y) were included. Family history of HAE was reported in 70% (36/51) of the cases; 33/46 patients became symptomatic by 18 years of age. The median time between onset of symptoms and diagnosis was 13 years (3 mo-50 y). The most frequent triggering factors for attacks were stress (74.4%), trauma (56.4%), and hormonal variations (56%). The main symptoms were subcutaneous edema in 93.5% (43/46) of patients, gastrointestinal symptoms in 84.8% (39/46), and obstruction in the upper airways in 34.8% (16/46). Hospitalization occurred in 65.2%, of whom 13.3% had to be transferred to the Intensive Care Unit. Prophylactic treatment was instituted in 87% (40/46) of patients, and 56.5% (26/46) required additional treatment to control attacks. Owing to our data collection over a period of 8 years, a significant number of patients were identified by this HAE reference center. Despite early recognition and prophylactic treatment, a high percentage of patients were hospitalized. HAE is still diagnosed late, reinforcing the need for more reference centers specialized in diagnosis and educational projects for health professionals.


Subject(s)
Humans , Male , Female , Child , Adolescent , Adult , Middle Aged , Aged , Young Adult , Complement C1 Inhibitor Protein/analysis , Hereditary Angioedema Types I and II/etiology , Hereditary Angioedema Types I and II/blood , Stress, Psychological/complications , Precipitating Factors , Risk Factors , Treatment Outcome , Age of Onset , Estrogen Antagonists/therapeutic use , Hereditary Angioedema Types I and II/prevention & control , Hereditary Angioedema Types I and II/drug therapy , Post-Exposure Prophylaxis/methods , Psychological Trauma/complications , Hospitalization , Antifibrinolytic Agents/therapeutic use , Nephelometry and Turbidimetry/methods
3.
Braz. j. med. biol. res ; 47(9): 746-752, 09/2014. graf
Article in English | LILACS | ID: lil-719312

ABSTRACT

Nonalcoholic fatty liver disease (NAFLD) is characterized by fat accumulation in the liver and is associated with obesity and insulin resistance. Activin A is a member of the transforming growth factor beta (TGF)-β superfamily and inhibits hepatocyte growth. Follistatin antagonizes the biological actions of activin. Exercise is an important therapeutic strategy to reduce the metabolic effects of obesity. We evaluated the pattern of activin A and follistatin liver expression in obese rats subjected to swimming exercise. Control rats (C) and high-fat (HF) diet-fed rats were randomly assigned to a swimming training group (C-Swim and HF-Swim) or a sedentary group (C-Sed and HF-Sed). Activin βA subunit mRNA expression was significantly higher in HF-Swim than in HF-Sed rats. Follistatin mRNA expression was significantly lower in C-Swim and HF-Swim than in either C-Sed or HF-Sed animals. There was no evidence of steatosis or inflammation in C rats. In contrast, in HF animals the severity of steatosis ranged from grade 1 to grade 3. The extent of liver parenchyma damage was less in HF-Swim animals, with the severity of steatosis ranging from grade 0 to grade 1. These data showed that exercise may reduce the deleterious effects of a high-fat diet on the liver, suggesting that the local expression of activin-follistatin may be involved.


Subject(s)
Animals , Male , Activins/metabolism , Exercise Therapy , Follistatin/metabolism , Non-alcoholic Fatty Liver Disease/metabolism , Obesity/therapy , Physical Exertion , Body Weight , Blood Glucose/analysis , Disease Models, Animal , Diet, High-Fat/adverse effects , Fatty Liver/metabolism , Fatty Liver/pathology , Gene Expression , Non-alcoholic Fatty Liver Disease/therapy , Obesity/metabolism , Random Allocation , Rats, Wistar , RNA, Messenger/metabolism , Swimming
4.
Arq. bras. med. vet. zootec ; 49(5): 617-28, out. 1997. tab
Article in Portuguese | LILACS | ID: lil-264569

ABSTRACT

Foram realizados dois experimentos com coelhas da raça Nova Zelândia Branco, com o objetivo de se avaliar o efeito de cinco fontes de fibra sobre a digestibilidade fecal e ileal. Calculou-se uma dieta padräo, na qual a principal fonte de fibra foi o feno de alfafa. As outras dietas se caracterizaram pela substituiçäo isométrica do feno de alfafa pelo feno de guandu, palha de feijäo, palha e sabugo de milho branco e feno de coast cross. utilizou-se a coleta total das fezes para determinaçäo da digestibilidade aparente. A digestibilidade das dietas foi afetada pelo uso das diferentes fontes de fibra. A dieta de palha e sabugo de milho branco apresentou o maior coeficiente de digestibilidade da proteína, no entanto a digestibilidade da MS, MO e EB foi significativamente inferior à dos demais tratamentos. Para a digestibilidade ileal utilizaram-se coelhas fistuladas no íleo e como indicadores o óxido crômico, a lignina e a fibra em detergente ácido. MSD, PD e MOD apresentaram valores significativamente diferentes entre os indicadores utilizados, sendo que a lignina mostrou resultados mais confiáveis como indicador da digestibilidade ileal


Subject(s)
Animals , Female , Dietary Fiber , Rabbits
SELECTION OF CITATIONS
SEARCH DETAIL